• August 5, 2016

    Commentary on – Seizing the Moment to Improve Addiction Treatment

    What about 1-Year Abstinence? I think the proposed standard of five years of continuous abstinence is simultaneously too long (we do not currently know how many people are abstinent for one week during treatment) – and also too short (we do not yet know at what point relapse risk approximates population rates). But like Bob DuPont, I too want to help improve the quality of care, and with it the level of understanding and confidence in addiction treatment by the public and by mainstream healthcare.
  • August 5, 2016

    Seizing the Moment to Improve Addiction Treatment

    The future of addiction treatment depends on the adoption of the long-term recovery standard to assess the effectiveness of our addiction treatments.
  • April 22, 2016

    Editorial Comment

    The opioid epidemic is finally reaching the average American's consciousness. This year, opioid overdoses have become an election year policy discussion for the presidential candidates. Additionally, 60 Minutes has run several primetime specials introducing the destruction caused by heroin and prescription opioid to every American household.
  • April 11, 2016

    Editorial Comment

    As specialists in addiction medicine we often face the task of educating those we treat, often by attempting to reduce a body of research to the most salient and actionable points and then presenting them in clear and understandable language. Our hope is usually a desire for them to leave with information that can improve their understanding, motivate to action, or both. In these one could argue we take on some of the job of the journalist.
  • April 5, 2016

    Letter of Thanks: Recognition of Addiction Medicine

    From the start, this endeavor was about the patients, and their affected family members. It was about building a workforce of trained and certified expert clinicians who would Treat Addiction and Save Lives™. We are today at a point in time, in a process begun by Dr. Ruth Fox and her colleagues in her apartment in New York City over 60 years ago, on the way to a future that we see clearly.
  • March 22, 2016

    Summary of Inter-Professional Collaboration

    A strong collaboration across different specialties is essential to produce a comprehensive treatment plan. This article highlights key points to consider in supporting inter-professional collaboration.
  • March 21, 2016

    Editorial Comment

    "Be careful what you ask for." In our discipline's quest for comprehensive guidelines for the management of opioid medications, these have been provided by the CDC in the past week, and are linked below. Depending on formatting, the reader will see over 50 pages, the greater part of which is, appropriately, discussion of the evidence for and against opioid use practices; “appropriately,” given the contentions associated with this topic. Naturally, that sort of reading assignment encourages condensation.
  • January 4, 2016

    Editor's Comments

    Trends and themes: Last year marked the 100th anniversary of the enactment of the Harrison Narcotics Tax Act, which, in regulating the access to opium derivatives and later, to cocaine and other intoxicants, created many of the same policy contradictions and arguments that we encounter today. Clinicians who insisted on providing maintenance dosing of paregoric, codeine, or morphine to their dependent patients found themselves facing de-licensure and prison...
  • December 15, 2015

    International Statement Recommending Against the Use of Terminology That Can Stigmatize People

    An editorial by Journal of Addiction Medicine Senior Editor, Dr. Richard Saitz, MPH, FACP, DFASAM, encourages the use of precise and non-stigmatizing terminology.
  • December 15, 2015

    Patients with Addiction Need Treatment - Not Stigma

    We must change the conversation about what it means to have a substance use disorder, and we also must increase access to evidence-based treatments.
  • December 14, 2015

    Editor's Comments

    Even with MAT, e.g., agonist therapy entailing buprenorphine, there is a range of understandings about appropriate maintenance dosages, duration of therapy, and compliance testing. This may be more true of the application of psychotherapies, and reflects the wide variety of treatment settings and of skill sets among therapists.
  • December 13, 2015

    Repurposing Medications to Treat Addiction?

    If researchers can get access to test new medications that have been developed and tested in human clinical trials for other non-addiction conditions, they could be proven effective for addiction treatment.
  • December 13, 2015

    Setting a New Standard for Treatment with Five-Year Recovery

    A new standard of five-year recovery has the potential to dramatically improve the way in which SUDs are managed, changing clinical practice and changing treatment outcome research.
  • October 9, 2015

    Creating a National Policy for State-level Debate

    Leading the writing committee to draft the “ASAM Public Policy Statement on Marijuana, Cannabinoids and Legalization” presented some unique challenges, writes Michael Miller, MD, FASAM, FAPA, in an Op-Ed about his role in revising ASAM's marijuana public policy statement.
  • October 9, 2015

    CMS Issues 1115 Waiver Mentioning ASAM's Criteria

    Medicaid is playing an increasingly important role as a payer for services provided to individuals with addiction in the United States. There have been some exciting developments regarding The ASAM Criteria in Medicaid's expanding role......"exciting" for me anyway, because I have been on a mission for 25 years to have The ASAM Criteria accepted as the model for addiction treatment's continuum of care.